Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Glycine, N-(6-((((4-(1h-pyrazol-1-yl)phenyl)methyl)(3-pyridinylsulfonyl)amino)methyl)-2-pyridinyl)-, 1-methylethyl Ester
2. Isopropyl N-(6-(((4-(1h-pyrazol-1-yl)benzyl)(3-pyridinylsulfonyl)amino)methyl)-2-pyridinyl)glycinate
1. 1187451-19-9
2. De-117
3. Omidenepag Isopropyl [usan]
4. G0g0h52u6k
5. Propan-2-yl N-(6-((n-((4-(1h-pyrazol-1-yl)phenyl)methyl)pyridine-3-sulfonamido)methyl)pyridin-2-yl)glycinate
6. Omidenepag Isopropyl (jan)
7. Omidenepag Isopropyl [jan]
8. Glycine, N-(6-((((4-(1h-pyrazol-1-yl)phenyl)methyl)(3-pyridinylsulfonyl)amino)methyl)-2-pyridinyl)-, 1-methylethyl Ester
9. Glycine, N-[6-[[[[4-(1h-pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]-2-pyridinyl]-, 1-methylethyl Ester
10. Eybelis (tn)
11. Unii-g0g0h52u6k
12. Chembl4297666
13. Schembl15414827
14. Tqr1222
15. Dtxsid001106409
16. Bcp26206
17. Ex-a4371
18. Bdbm50506549
19. Omidenepag Isopropyl [who-dd]
20. At36244
21. Db15071
22. Sb18739
23. Hy-111406
24. Cs-0040499
25. Omdi;de-117; De 117; De117
26. D10966
27. Q27896252
28. Isopropyl 2-((6-((n-(4-(1h-pyrazol-1-yl)benzyl)pyridine-3-sulfonamido)methyl)pyridin-2-yl)amino)acetate
29. N-[6-[[[[4-(1h-pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]-2-pyridinyl]glycine 1-methylethyl Ester
30. Propan-2-yl 2-[[6-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]pyridin-2-yl]amino]acetate
Molecular Weight | 520.6 g/mol |
---|---|
Molecular Formula | C26H28N6O4S |
XLogP3 | 3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 12 |
Exact Mass | 520.18927457 g/mol |
Monoisotopic Mass | 520.18927457 g/mol |
Topological Polar Surface Area | 128 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 814 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Omidenepag Isopropyl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Omidenepag Isopropyl, including repackagers and relabelers. The FDA regulates Omidenepag Isopropyl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Omidenepag Isopropyl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Omidenepag Isopropyl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Omidenepag Isopropyl supplier is an individual or a company that provides Omidenepag Isopropyl active pharmaceutical ingredient (API) or Omidenepag Isopropyl finished formulations upon request. The Omidenepag Isopropyl suppliers may include Omidenepag Isopropyl API manufacturers, exporters, distributors and traders.
click here to find a list of Omidenepag Isopropyl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Omidenepag Isopropyl DMF (Drug Master File) is a document detailing the whole manufacturing process of Omidenepag Isopropyl active pharmaceutical ingredient (API) in detail. Different forms of Omidenepag Isopropyl DMFs exist exist since differing nations have different regulations, such as Omidenepag Isopropyl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Omidenepag Isopropyl DMF submitted to regulatory agencies in the US is known as a USDMF. Omidenepag Isopropyl USDMF includes data on Omidenepag Isopropyl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Omidenepag Isopropyl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Omidenepag Isopropyl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Omidenepag Isopropyl Drug Master File in Japan (Omidenepag Isopropyl JDMF) empowers Omidenepag Isopropyl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Omidenepag Isopropyl JDMF during the approval evaluation for pharmaceutical products. At the time of Omidenepag Isopropyl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Omidenepag Isopropyl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Omidenepag Isopropyl Drug Master File in Korea (Omidenepag Isopropyl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Omidenepag Isopropyl. The MFDS reviews the Omidenepag Isopropyl KDMF as part of the drug registration process and uses the information provided in the Omidenepag Isopropyl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Omidenepag Isopropyl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Omidenepag Isopropyl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Omidenepag Isopropyl suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Omidenepag Isopropyl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Omidenepag Isopropyl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Omidenepag Isopropyl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Omidenepag Isopropyl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Omidenepag Isopropyl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Omidenepag Isopropyl suppliers with NDC on PharmaCompass.
Omidenepag Isopropyl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Omidenepag Isopropyl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Omidenepag Isopropyl GMP manufacturer or Omidenepag Isopropyl GMP API supplier for your needs.
A Omidenepag Isopropyl CoA (Certificate of Analysis) is a formal document that attests to Omidenepag Isopropyl's compliance with Omidenepag Isopropyl specifications and serves as a tool for batch-level quality control.
Omidenepag Isopropyl CoA mostly includes findings from lab analyses of a specific batch. For each Omidenepag Isopropyl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Omidenepag Isopropyl may be tested according to a variety of international standards, such as European Pharmacopoeia (Omidenepag Isopropyl EP), Omidenepag Isopropyl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Omidenepag Isopropyl USP).
LOOKING FOR A SUPPLIER?